» Articles » PMID: 33423960

Untangling a Complex Web: Computational Analyses of Tumor Molecular Profiles to Decode Driver Mechanisms

Overview
Publisher Science Press
Specialty Genetics
Date 2021 Jan 11
PMID 33423960
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Genome-scale studies focusing on molecular profiling of cancers across tissue types have revealed a plethora of aberrations across the genomic, transcriptomic, and epigenomic scales. The significant molecular heterogeneity across individual tumors even within the same tissue context complicates decoding the key etiologic mechanisms of this disease. Furthermore, it is increasingly likely that biologic mechanisms underlying the pathobiology of cancer involve multiple molecular entities interacting across functional scales. This has motivated the development of computational approaches that integrate molecular measurements with prior biological knowledge in increasingly intricate ways to enable the discovery of driver genomic aberrations across cancers. Here, we review diverse methodological approaches that have powered significant advances in our understanding of the genomic underpinnings of cancer at the cohort and at the individual tumor scales. We outline the key advances and challenges in the computational discovery of cancer mechanisms while motivating the development of systems biology approaches to comprehensively decode the biologic drivers of this complex disease.

Citing Articles

A Mouse-Specific Model to Detect Genes under Selection in Tumors.

Chen H, Shu J, Maley C, Liu L Cancers (Basel). 2023; 15(21).

PMID: 37958330 PMC: 10647215. DOI: 10.3390/cancers15215156.


Increased Cell Proliferation as a Key Event in Chemical Carcinogenesis: Application in an Integrated Approach for the Testing and Assessment of Non-Genotoxic Carcinogenesis.

Strupp C, Corvaro M, Cohen S, Corton J, Ogawa K, Richert L Int J Mol Sci. 2023; 24(17).

PMID: 37686053 PMC: 10488128. DOI: 10.3390/ijms241713246.


SYSMut: decoding the functional significance of rare somatic mutations in cancer.

Khalighi S, Joseph P, Babu D, Singh S, LaFramboise T, Guda K Brief Bioinform. 2022; 23(4).

PMID: 35804437 PMC: 9618165. DOI: 10.1093/bib/bbac280.

References
1.
Quang D, Chen Y, Xie X . DANN: a deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics. 2014; 31(5):761-3. PMC: 4341060. DOI: 10.1093/bioinformatics/btu703. View

2.
Akavia U, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, Causton H . An integrated approach to uncover drivers of cancer. Cell. 2010; 143(6):1005-17. PMC: 3013278. DOI: 10.1016/j.cell.2010.11.013. View

3.
Tang H, Thomas P . PANTHER-PSEP: predicting disease-causing genetic variants using position-specific evolutionary preservation. Bioinformatics. 2016; 32(14):2230-2. DOI: 10.1093/bioinformatics/btw222. View

4.
Shuai S, Gallinger S, Stein L . Combined burden and functional impact tests for cancer driver discovery using DriverPower. Nat Commun. 2020; 11(1):734. PMC: 7002750. DOI: 10.1038/s41467-019-13929-1. View

5.
Pickar-Oliver A, Gersbach C . The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol. 2019; 20(8):490-507. PMC: 7079207. DOI: 10.1038/s41580-019-0131-5. View